John Dunn

General Counsel at CALCIMEDICA, INC.

74 year

Health Technology

Commercial Services

Consumer Services

Profile

Mr. John M.
Dunn is a General Counsel at CalciMedica, Inc. He is on the Board of Directors at Agility Clinical, Inc., CONNECT and The University of Wyoming Foundation.
Mr. Dunn was previously employed as an Independent Director by Acer Therapeutics, Inc., a Secretary & General Counsel by Vital Therapies, Inc., an Executive Vice President by Biogen Idec, Inc., an Executive Vice President by Biogen Idec New Ventures, Inc., a Secretary, Senior VP-Legal & Compliance by IDEC Pharmaceuticals Corp., and a Partner by Pillsbury Winthrop LLP.
He also served on the board at Sharp HealthCare, Opexa Therapeutics, Inc., Acer Therapeutics, Inc. /Old/ and Biocom, Inc. He received his undergraduate degree from the University of Wyoming and a graduate degree from the University of Wyoming.

John Dunn active positions

Companies	Position	Start
CALCIMEDICA, INC.	General Counsel	20/03/2023
Agility Clinical, Inc. Agility Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a specialty consulting and clinical research organization	Director/Board Member	-
CONNECT CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services	Director/Board Member	-
The University of Wyoming Foundation The University of Wyoming Foundation Investment Trusts/Mutual FundsMiscellaneous Foundation	Director/Board Member	-

All active positions of John Dunn

Former positions of John Dunn

Companies	Position	End
ACER THERAPEUTICS INC.	Director/Board Member	17/11/2023
Vital Therapies, Inc. Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy	General Counsel	12/04/2019
BIOGEN INC.	Corporate Officer/Principal	01/01/2012
Biogen Idec New Ventures, Inc. Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments.	Corporate Officer/Principal	31/12/2008
IDEC Pharmaceuticals Corp. IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases	Compliance Officer	01/11/2003

See the detail of John Dunn's experience

Training of John Dunn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Dunn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Agility Clinical, Inc. Agility Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a specialty consulting and clinical research organization	Commercial Services
Acer Therapeutics, Inc. /Old/ Acer Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of orphan diseases.	Health Technology
Pillsbury Winthrop LLP Pillsbury Winthrop LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
IDEC Pharmaceuticals Corp. IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases	Health Technology
Vital Therapies, Inc. Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy	Health Technology
University of Wyoming University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BIOCOM BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services	Commercial Services
Sharp HealthCare Sharp HealthCare Hospital/Nursing ManagementHealth Services Operates acute care and specialty hospitals	Health Services
Biogen Idec New Ventures, Inc. Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments.	Finance
Opexa Therapeutics, Inc. Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases.	Health Technology
CONNECT CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services	Commercial Services
The University of Wyoming Foundation The University of Wyoming Foundation Investment Trusts/Mutual FundsMiscellaneous Foundation	Miscellaneous
Acer Therapeutics, Inc. Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases	Health Technology
CalciMedica, Inc. CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company	Health Technology

See company connections